Fund Holdings — Medicxi Ventures Management (Jersey) Ltd

Total Portfolio Value
$744.42M
Total Bought
$72.06M
Total Sold
$22.35M
Net Transaction
+$49.71M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CENTESSA PHARMACEUTICALS PLC19,963,15719,963,1570262,316484,10765.03%+221,791
RAPT THERAPEUTICS INC02,794,000+2,794,000072,0579.68%+72,057
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
2,869,5652,869,565051,96881,61010.96%+29,643
PHATHOM PHARMACEUTICALS INC(PHAT)7,464,5727,464,572071,58587,85811.80%+16,273
AURA BIOSCIENCES INC(AURA)3,039,8923,039,892019,03018,7872.52%-243
RAPT THERAPEUTICS INC2,794,0000-2,794,00022,3520—-22,352
Page 1 of 1
Medicxi Ventures Management (Jersey) Ltd — 13F Holdings — Q3 2025 | TickerTrail